Difficulty: Medium
Average Score: 95%
Practice
Tolerance and drug resistance can be a consequence of:
Correct answer
B
Rationale
In pharmacology, tolerance and drug resistance are important concepts that healthcare providers must understand to ensure safe and effective patient care. The correct answer, option B, "Increased metabolic degradation," is key to understanding how tolerance and drug resistance can occur.
When a drug is metabolized more rapidly in the body, it can lead to reduced drug concentrations and efficacy over time. This phenomenon can result in the need for higher doses of the drug to achieve the same therapeutic effect, ultimately leading to tolerance. Increased metabolic degradation can also contribute to drug resistance as the body becomes more efficient at breaking down and eliminating the drug before it can exert its intended effects.
Option A, "Drug dependence," while a potential consequence of prolonged drug use, does not directly lead to tolerance or drug resistance. Drug dependence is characterized by physical or psychological reliance on a drug but does not necessarily impact the body's ability to metabolize the drug.
Option C, "Depressed renal drug excretion," and Option D, "Activation of a drug after hepatic first-pass," are not directly related to tolerance or drug resistance. Depressed renal drug excretion may lead to increased drug concentrations in the body, potentially causing toxicity, but it does not directly contribute to tolerance. Activation of a drug after hepatic first-pass refers to the conversion of a prodrug to its active form, which is a different mechanism than that involved in tolerance and drug resistance.
Understanding the mechanisms behind tolerance and drug resistance is crucial for healthcare providers to make informed decisions about drug therapy and patient management. By recognizing the role of increased metabolic degradation in these phenomena, providers can adjust treatment plans as needed to optimize patient outcomes.
When a drug is metabolized more rapidly in the body, it can lead to reduced drug concentrations and efficacy over time. This phenomenon can result in the need for higher doses of the drug to achieve the same therapeutic effect, ultimately leading to tolerance. Increased metabolic degradation can also contribute to drug resistance as the body becomes more efficient at breaking down and eliminating the drug before it can exert its intended effects.
Option A, "Drug dependence," while a potential consequence of prolonged drug use, does not directly lead to tolerance or drug resistance. Drug dependence is characterized by physical or psychological reliance on a drug but does not necessarily impact the body's ability to metabolize the drug.
Option C, "Depressed renal drug excretion," and Option D, "Activation of a drug after hepatic first-pass," are not directly related to tolerance or drug resistance. Depressed renal drug excretion may lead to increased drug concentrations in the body, potentially causing toxicity, but it does not directly contribute to tolerance. Activation of a drug after hepatic first-pass refers to the conversion of a prodrug to its active form, which is a different mechanism than that involved in tolerance and drug resistance.
Understanding the mechanisms behind tolerance and drug resistance is crucial for healthcare providers to make informed decisions about drug therapy and patient management. By recognizing the role of increased metabolic degradation in these phenomena, providers can adjust treatment plans as needed to optimize patient outcomes.